Immunotherapy for Egg Allergy Shows Promise in Long-Term Study

Researchers and clinicians in attendance at the annual American Academy of Allergy, Asthma, and Immunology (AAAAI) conference are readily cognizant to the widespread impact...

Top 10 Immuno-Oncology Startups of 2018

Numerous firms have ventured their best projections for the size of the cancer immunotherapy market over the next few years, the highest of which forecasts that the market will reach $173 billion by 2024, according to Market Research Engine.

Stroke Recovery May Be Assisted by HIV Drug, Suggests Study of...

Hints have been accumulating that maraviroc, a drug for slowing HIV, could benefit patients who have suffered mild stroke. A few years ago, maraviroc...

Triclosan Added to Consumer Products Dramatically Decreases Antibiotic Efficacy

New research finds a chemical that is supposed to kill bacteria is making them stronger and more capable of surviving antibiotic treatment. The study suggests that triclosan exposure may inadvertently drive bacteria into a state in which they are able to tolerate normally lethal concentrations of antibiotics.

Colorectal Cancer Stem Cell Growth Driven by High-Fat Diet and Altered...

Studies by Salk Institute scientists have suggested how high-fat diets may fuel the early development of colorectal cancer in people who have a common...

Cancer Immunotherapy BiTE Method May Identify Patients Who Will Benefit Most

Scientists at Osaka University and colleagues have revealed a correlation between the cancer cell-killing activity of T cells within tumors in lung cancer patients...

Merck to Acquire Immune Design for $300M, Boosting Immunotherapy Vaccine Pipeline

Merck & Co. said today it has agreed to acquire Immune Design for approximately $300 million, in a deal designed to boost the buyer’s...

Antibiotic Resistant Gene Blocked by Novel Combination Therapy

Scientists in Canada say they have found a method to block the VCC-1 enzyme, which disables the VCC-1 antimicrobial-resistance gene. VCC-1, a ß-lactamase gene, has been discovered in benign close relatives of virulent Vibrio cholerae, which causes cholera.

Flesh-Eating Bacteria’s Genomic/Transcriptomic Trigger Found

Coordinating the sort of full-spectrum analysis more commonly deployed in cancer research, scientists based at Houston Methodist examined flesh-eating strains of Streptococcus pyogenes both...

Novartis Creates “Inflection Point” for AbCellera with 10-Target Antibody Collaboration

Novartis will use AbCellera’s antibody discovery platform and single-cell screening technology to identify and develop up to 10 targets, through a collaboration whose value...

Recently Featured

Stay Connected

555,239FansLike
49,749FollowersFollow
Scroll Up